IBA Lifesciences — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

IBA Lifesciences is a long-established provider of research tools centered on its patented Strep-tag®/Strep-Tactin®XT protein purification and analysis platform. The company's products, including resins, magnetic beads, and assay-ready plates, are used in applications ranging from basic protein purification to antibody development and drug discovery. In a significant recent development, the company was acquired by Cube Biotech, a specialist in membrane protein technologies, marking a strategic consolidation in the research tools sector.

DiagnosticsProteomicsAntibodies

Technology Platform

Proprietary Strep-tag®/Strep-Tactin®XT affinity system for the purification and analysis of recombinant proteins. Includes Strep-tag®II and Twin-Strep-tag® peptide tags that bind with high affinity and specificity to the engineered streptavidin derivative, Strep-Tactin®XT. Commercialized as resins, magnetic beads, coated plates, and assay kits.

Opportunities

The acquisition by Cube Biotech creates a significant opportunity to integrate the gentle Strep-tag® purification platform with cutting-edge membrane protein production technologies, addressing a major bottleneck in structural biology and drug discovery.

Growing demand for high-quality protein reagents to support AI-driven drug discovery and biologics development presents a expanding market for the company's high-purity tools.

Risk Factors

Intense competition from larger, diversified reagent companies offering alternative affinity tag systems (e.g., His-tag) poses a constant threat to market share.

Successful integration post-acquisition with Cube Biotech is critical to realizing projected synergies and avoiding operational disruption.

The company's niche focus makes it susceptible to fluctuations in global research and development funding cycles.

Competitive Landscape

IBA competes in the affinity chromatography and protein research tools market against giants like Thermo Fisher Scientific, Cytiva, and MilliporeSigma, which offer a wide array of tags and purification systems. Its differentiation lies in the specific performance advantages of the Strep-tag® system (high purity, gentle elution). The acquisition by Cube Biotech shifts the competitive dynamic, creating a more integrated, specialty player focused on challenging protein targets.

More companies in Proteomics & Protein Engineering →More companies in Germany →